UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

Strategic Partnership Expands Access to Innovative Wound Care Solution Across CanadaWINNIPEG, Manitoba, March 11, 2025 (GLOBE ...

Calgary-based NanoTess makes a gel called NanoSALV that's designed to to help heal chronic wounds, skin injuries, infections ...

In a groundbreaking achievement, researchers from Aalto University and the University of Bayreuth have successfully developed a self-healing ...

Scientists have created a self-healing hydrogel that mimics human skin, offering a breakthrough solution for complete wound ...

WINNIPEG, Manitoba, March 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech”) announces that it has concluded a three-year distribution agreement with Best ...